US Stock MarketDetailed Quotes

NRIX Nurix Therapeutics

Watchlist
  • 17.590
  • +0.020+0.11%
Close Feb 14 16:00 ET
  • 17.590
  • 0.0000.00%
Post 17:01 ET
1.33BMarket Cap-6.11P/E (TTM)

Nurix Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Nurix Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 13 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 13.648M--
--2025/Q1-- / 12.781M--
--2024/Q413.284M / 12.877M--
--2024/Q312.588M / 12.253M--
--2024/Q212.092M / 21.784M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 13.648M--
--2025/Q1-- / 12.781M--
--2024/Q413.284M / 12.877M--
--2024/Q312.588M / 12.253M--
--2024/Q212.092M / 21.784M--

Unlock Free Earnings Estimates

Nurix Therapeutics Earnings Reports

  • Nurix Therapeutics | 10-K: FY2024 Annual Report

    Jan 28 16:22 ET

  • Nurix Therapeutics | 8-K: Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides a Corporate Update

    Jan 28 16:05 ET

  • Nurix Therapeutics | 10-Q: Q3 2024 Earnings Report

    Oct 11, 2024 16:10 ET

  • Nurix Therapeutics | 10-Q: Q2 2024 Earnings Report

    Jul 11, 2024 16:09 ET

    • Read more

    Trending Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
    DMZPY
    +17.56%
    DexCom
    DXCM
    +5.92%
    Hutchmed (China)
    HCM
    +4.39%
    New Fortress Energy
    NFE
    +2.70%
    Enerpac Tool
    EPAC
    +1.85%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Feb 17, 2025

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data